KRISAFLIS Trademark

Trademark Overview

On Friday, January 14, 2011, a trademark application was filed for KRISAFLIS with the United States Patent and Trademark Office. The USPTO has given the KRISAFLIS trademark a serial number of 85218049. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 9, 2021. This trademark is owned by Glaxo Group Limited. The KRISAFLIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
krisaflis

General Information

Serial Number85218049
Word MarkKRISAFLIS
Filing DateFriday, January 14, 2011
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 9, 2021
Registration Number4595125
Registration DateTuesday, September 2, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Friday, April 9, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, December 10, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 10, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 2, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 2, 2014REGISTERED-PRINCIPAL REGISTER
Thursday, July 24, 20141(B) BASIS DELETED; PROCEED TO REGISTRATION
Friday, July 18, 2014NOTICE OF ALLOWANCE CANCELLED
Friday, July 18, 2014TEAS DELETE 1(B) BASIS RECEIVED
Saturday, February 15, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 14, 2014EXTENSION 5 GRANTED
Thursday, February 6, 2014EXTENSION 5 FILED
Thursday, February 6, 2014TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 3, 2013EXTENSION 4 GRANTED
Tuesday, July 30, 2013EXTENSION 4 FILED
Tuesday, July 30, 2013TEAS EXTENSION RECEIVED
Thursday, June 6, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 6, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 24, 2013EXTENSION 3 GRANTED
Thursday, January 17, 2013EXTENSION 3 FILED
Thursday, January 17, 2013TEAS EXTENSION RECEIVED
Friday, August 17, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 16, 2012EXTENSION 2 GRANTED
Friday, August 3, 2012EXTENSION 2 FILED
Thursday, August 16, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 3, 2012TEAS EXTENSION RECEIVED
Wednesday, January 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 16, 2012EXTENSION 1 GRANTED
Monday, January 16, 2012EXTENSION 1 FILED
Monday, January 16, 2012TEAS EXTENSION RECEIVED
Tuesday, August 23, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 28, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 28, 2011PUBLISHED FOR OPPOSITION
Monday, May 23, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 20, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 20, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 20, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 4, 2011ASSIGNED TO LIE
Tuesday, May 3, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 31, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 31, 2011NON-FINAL ACTION E-MAILED
Thursday, March 31, 2011NON-FINAL ACTION WRITTEN
Wednesday, March 30, 2011ASSIGNED TO EXAMINER
Thursday, January 20, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 18, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

krisaflis pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic